Department of Health and Human Services, through National Institutes of Health, awarded Biological Mimetics, Inc. of Frederick, MD $1,498,641 under the SBIR program (Phase II), with work starting 2025-09-15 and running to 2028-09-14. It is one of 2 SBIR and STTR awards Biological Mimetics, Inc. received in the last two years, $2,064,963 in all. Each figure links to the federal record.
The award
| Recipient | Biological Mimetics, Inc. (Frederick, MD) |
|---|---|
| Awarding agency | Department of Health and Human Services |
| Awarding office | National Institutes of Health |
| Phase | Phase II |
| Amount obligated | $1,498,641 |
| Period of performance starts | 2025-09-15 |
| Period of performance ends | 2028-09-14 |
| Award number | 75N93025C00031 (contract) |
| Industry (NAICS) | 541714, Research and development in biotechnology (except nanobiotechnology) |
| Product or service code | AN12, Health R&D services; health care services; applied research |
| Place of performance | Frederick, Frederick County, MD |
| Signed | 2025-09-25 |
| Recipient registry id (UEI) | LJARDLY9MMK5 |
Want the whole picture on Biological Mimetics, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Biological Mimetics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Biological Mimetics, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
19 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
What it is for
Biological mimetics, inc. Award
Funding actions on this award
| Date | Action | Modification | Amount |
|---|---|---|---|
| 2026-07-17 | Other administrative action | P00001 | $0 |
| 2025-09-25 | Initial award | 0 | $1,498,641 |
From the federal award record.
Other SBIR and STTR awards to Biological Mimetics, Inc.
| Starts | Agency | Program | Amount | Project |
|---|---|---|---|---|
| 2024-12-23 | Department of Health and Human Services | SBIR Phase I | $566,322 | A subunit vaccine against acinetobacter baumannii - project title: Development of a novel (record) |
Every other federal award to Biological Mimetics, Inc. on record
The federal register lists 17 other awards to the same registry id (UEI LJARDLY9MMK5), $14,108,413 in all, from 4 agencies.
| Starts | Agency | Amount | Award |
|---|---|---|---|
| 2024-06-01 | National Institutes of Health | $588,900 | An instrument-free malaria diagnostic - abstract we propose to develop a sensitive, rapid, and affordable cris (R43AI179513) |
| 2023-09-20 | National Institutes of Health | $592,884 | Development of a staph aureus vaccine - abstract methicillin-resistant staphylococcus aureus is often consider (R43AI174497) |
| 2023-09-15 | National Institutes of Health | $299,820 | Phase I SBIR biological mimetics, inc. Award (75N93023C00056) |
| 2023-07-01 | National Institute of Food and Agriculture | $174,958 | The u.s pork industry produces an estimated 2.2 metric tons of pork annually, valued at $23.4 billion, of whic (20235140239491) |
| 2020-07-05 | National Institutes of Health | $598,436 | Development of a universal influenza vaccine (R43AI152652) |
| 2019-04-05 | National Institutes of Health | $224,957 | Whole-cell vaccine development for mrsa (R43AI145457) |
| 2019-01-01 | National Institutes of Health | $224,958 | Development of a cross-protective hrv vaccine (R43AI142830) |
| 2018-09-11 | National Institutes of Health | $299,372 | Manganese-peptide countermeasures for radiation exposure (R43AI140809) |
| 2018-01-18 | National Institutes of Health | $224,956 | Improved rsv f vaccine candidates (R43AI122411) |
| 2017-06-22 | Defense Threat Reduction Agency | $1,140,081 | T2-0243 - STTR Phase II (HDTRA117C0030) |
| 2015-09-29 | Department of the Army | $99,794 | Ph i proposal h151-051-0006 (W81XWH15C0183) |
| 2015-09-24 | Defense Threat Reduction Agency | $149,992 | Reports - STTR Phase I (HDTRA115P0034) |
| 2015-05-15 | National Institutes of Health | $4,350,456 | Development of an improved, low-cost polio vaccine (ir-ipv) (R44AI120260) |
| 2015-05-15 | National Institutes of Health | $224,887 | Development of a new low-cost poliovirus vaccine (ir-ipv): Feasibility study with PV-2 (R43AI120260) |
| 2010-07-05 | National Institutes of Health | $597,509 | Development of a novel human rhinovirus vaccine (R43AI085683) |
| 2009-11-01 | National Institutes of Health | $2,923,090 | Development of the first hrv vaccine (R44AI085683) |
| 2008-09-03 | Departmental Offices | $1,393,362 | New contract effort: Longitudinal modeling for spontaneous emergence of modularity (IND08PC75336) |
Who runs it, who owns it, where the money comes from and what to watch for, every claim linked to its source.
Order Full Report on Biological Mimetics, Inc.Look up Biological Mimetics, Inc. and see what is on record before you decide.
Get the free SnapshotWhere this comes from
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs set aside part of federal research budgets for small companies. Agencies award them in phases: Phase I tests whether an idea is feasible, Phase II funds development, and Phase III is follow-on work paid for outside the set-aside. STTR awards also require a research institution as a partner.
Every figure on this page is taken from the award's own federal record, linked beside it, as it stood when the page was built: the recipient, its address, the awarding agency and office, the amount obligated so far, the dates and the description. Phase and program are shown as the award's own description states them. The amount can grow later if the agency adds funding to the same award.